We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.newsWe've updated our Privacy Policy with additional info on research surveys, our browser extension, cookie management, and ad performance measurement. Questions? Email us any time at privacy@ground.news
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) lowered its 2026 revenue outlook after integration of the acquired Biotronik Vascular Intervention business took longer than expected, even as second-quarter continuing-operations revenue …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.